Literature DB >> 18222983

Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA.

D U Cansu, C Korkmaz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18222983     DOI: 10.1093/rheumatology/kem378

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  21 in total

1.  Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Sara Kaprove Penn; Amy H Kao; Laura L Schott; Jennifer R Elliott; Frederico G S Toledo; Lewis Kuller; Susan Manzi; Mary Chester M Wasko
Journal:  J Rheumatol       Date:  2010-05-01       Impact factor: 4.666

2.  Practice guidelines for pharmacists: The pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Authors:  Carolyn Bornstein; Marie Craig; Diane Tin
Journal:  Can Pharm J (Ott)       Date:  2014-03

Review 3.  A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role.

Authors:  Mirella P Hage; Marwa R Al-Badri; Sami T Azar
Journal:  Ther Adv Endocrinol Metab       Date:  2014-08       Impact factor: 3.565

Review 4.  Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.

Authors:  Prasad Katulanda; Harsha A Dissanayake; Ishara Ranathunga; Vithiya Ratnasamy; Piyumi S A Wijewickrama; Nilukshana Yogendranathan; Kavinga K K Gamage; Nipun L de Silva; Manilka Sumanatilleke; Noel P Somasundaram; David R Matthews
Journal:  Diabetologia       Date:  2020-05-14       Impact factor: 10.122

Review 5.  Hydroxychloroquine-induced hypoglycaemia in non-diabetic renal patient on peritoneal dialysis.

Authors:  Ahmed El-Solia; Khalid Al-Otaibi; Abdullah K Ai-Hwiesh
Journal:  BMJ Case Rep       Date:  2018-04-18

Review 6.  Drug-induced hypoglycaemia: an update.

Authors:  Chaker Ben Salem; Neila Fathallah; Houssem Hmouda; Kamel Bouraoui
Journal:  Drug Saf       Date:  2011-01-01       Impact factor: 5.606

7.  Hydroxychloroquine as a glucose lowering drug.

Authors:  Elizabeth Martha Winter; Anita Schrander-van der Meer; Carmen Eustatia-Rutten; Martien Janssen
Journal:  BMJ Case Rep       Date:  2011-10-28

Review 8.  Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.

Authors:  Scott J Pilla; Amy Q Quan; Emily L Germain-Lee; David B Hellmann; Nestoras N Mathioudakis
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

Review 9.  Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.

Authors:  Domenico Plantone; Tatiana Koudriavtseva
Journal:  Clin Drug Investig       Date:  2018-08       Impact factor: 3.580

Review 10.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.